22 – 24 April 2015, Big Sight Exhibition Centre – West Hall 1, 2 and Atrium, Tokyo, Japan
CPhI Japan and co-located events ICSE, P-MEC | LABWorld, BioPh andInnoPack are the ultimate one-stop-shop for all pharma relevant activity concerning Japan.
With a wide range of companies from all areas of pharma active in Japan as well as free to attend seminars presented by governmental bodies and other important institutions, CPhI Japan is all you need to successfully enter this highly profitable market.
As Asia’s leading pharma industry and the world’s second largest market, Japan is the right country to find the latest technologies and innovative products. Changes in the market environment, together with an aging population result in a great drug demand, especially in the generic and biotechnology sectors.
Building partnerships and understanding the market are crucial success factors in this growing market – expected to be valued at US $ 166 billion in 2023.
5 Pharma Events in 1
The Biggest and Most International Pharmaceutical Ingredient Event in Japan
Japan has a huge and well established pharmaceutical market with high quality drug standards. It is predicted to be worth US$ 166 billion by 2023. The generics sector is predicted to be worth US$ 12.3 billion by 2015 and its volume is expected to increase over 60% by 2018. As the use of generic drugs in Japan continues to expand, Japanese pharmaceutical manufacturers and traders are urgently seeking to secure new and reliable suppliers of price-competitive – and high-quality – pharmaceutical ingredients. This trend is providing profitable new business opportunities to international API suppliers.